Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

What Producers Need To Know About Health Canada’s Latest Food Additive, Enzyme And Supplement Updates

Health Canada and the Canadian Food Inspection Agency have introduced significant regulatory updates affecting food additives, enzymes, and supplements that took effect in late 2025 and early 2026. These changes represent a modernization effort aimed at creating a more flexible regulatory framework that can respond quickly to market innovations and new processing technologies. Agricultural producers and food manufacturers need to understand how these updates impact compliance requirements and market opportu

Canada Healthcare

MA

MLT Aikins LLP

A New Channel: Spirit-Based Ready-To-Drink Beverages In Quebec Grocery Stores

This bulletin provides an overview of the current framework governing spirit-based RTD beverages in Quebec, along with the proposed changes and their potential impact on producers and distributors of spirit‑based RTD beverages in Quebec.

Canada Healthcare

F

Fasken

Un Nouveau Marché : Les Prêts-à-boire À Base De Spiritueux Arrivent Dans Les Épiceries Du Québec

Québec a récemment déposé le Projet de loi n° 11, Loi modifiant diverses dispositions principalement aux fins d’allègement du fardeau réglementaire et administratif (le « Projet de loi »), lequel vise, entre autres choses, à permettre la vente de prêts-à-boire à base de spiritueux dans les épiceries.

Canada Healthcare

FF

Fasken (French)

NEW: Ad Standards’ Updated Code For Food & Beverage Advertising To Children

Recently, Ad Standards Canada published the updated Code for the Restriction of Food and Beverage Product Advertising to Children (the “Updated Code”), replacing the earlier Code for the Responsible Advertising of Food and Beverage Products to Children.

Canada Healthcare

F

Fasken

NEW: Ad Standards’ Updated Code For Food & Beverage Advertising To Children

Canada Healthcare

F

Fasken

CFIA Addresses Stakeholders’ "Eggspectations” Regarding Proposed Guidance On Plant‑Based Egg Alternatives

Canada Healthcare

F

Fasken

Canada's Dormant DIN Problem: How Marketing Status Is Undermining Pharmaceutical IP Protections Under CUSMA

MT

McCarthy Tétrault LLP

Federal Court Dismisses C$5 Billion Generic Drug Price-Fixing Class Action

Canada Healthcare

BJ

Bennett Jones LLP

Canada's Agri-food Equity Gap: Why Growth Capital Is The Sector's Missing Ingredient

Canada Healthcare

MA

MLT Aikins LLP

Canada Launches Safeguard Inquiry Into Imports Of Certain Vegetable Goods

Canada International

MT

McCarthy Tétrault LLP

Réglementation des emballages : Développements touchant l’agroalimentaire et les produits alimentaires et embouteillés

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

Association Is Not Causation: Ontario Court Dismisses Drug Liability Claim Against AstraZeneca

Canada Litigation

ML

McMillan LLP

L'intelligence artificielle prescrira-t-elle bientôt des médicaments au Canada? Les leçons du programme novateur de l'Utah

Canada Healthcare

FF

Fasken (French)

Canada Launches Safeguard Inquiry Into Frozen And Canned Vegetable Imports

Canada International

C

Cassels

Understanding CRA Form T106 And How It Compares To U.S. Reporting Requirements

RS

Rotfleisch & Samulovitch P.C.

Tax Court Of Canada Overturns CRA’s Denial Of GST/HST Input Tax Credits: Fiera Foods Company v The King

RS

Rotfleisch & Samulovitch P.C.

Why Canada’s Workforce Math Doesn’t Work Without Immigration

Canada Immigration

Moving2Canada

Fake It Till You Make It? Kings Bench Says “No”

Canada Employment

BR

Bow River Law

The Federal Government And Musqueam Nation Sign Historic Agreements Recognizing Aboriginal Land Title | CityNews Interview With Anita Boscariol (Video)

Canada Government

WG

Watson Goepel LLP

Canada Launches Safeguard Inquiry Into Frozen And Canned Vegetable Imports

The Canadian International Trade Tribunal (CITT) has initiated a safeguard inquiry that may have significant implications for businesses involved in the production...

Canada International

C

Cassels

Could Artificial Intelligence Soon Prescribe Drugs In Canada? Lessons From Utah's Landmark Program

Canadian regulators may soon face new questions about the role of autonomous artificial intelligence ("AI") in healthcare delivery, as the state of Utah has launched a pilot program...

Canada Healthcare

F

Fasken

Torys On Defence: The Role Of Life Sciences In Canada's Defence Capabilities

Last month, Canada released its first Defence Industrial Strategy (the Strategy), which outlines Canada's commitment to develop a strong defence industrial base and boost economic growth.

Canada Healthcare

TL

Torys LLP

New Controlled Substances Regulations To Consolidate Existing Regulatory Scheme

As of October 1, 2026, the Controlled Substances Regulations (CSR) will establish a comprehensive framework to govern the activity of controlled substances and cannabis...

Canada Healthcare

TL

Torys LLP

Aller de l'avant: Points clés du 16e Sommet du commerce de détail et des biens de consommation

Canada Consumer

MT

McCarthy Tétrault LLP

U.S.–Canada Tariffs: Timeline Of Key Dates And Documents

Canada International

BC

Blake, Cassels & Graydon LLP

Health Canada Eliminates The Foreign Site Reference Number (FSRN) Process: Immediate Impact On Importers And Foreign Sites

Canada Healthcare

GW

Gowling WLG

Driving Forward: Key Takeaways From The 16th Anniversary Edition Of McCarthy Tétrault's Annual Retail And Consumer Markets Summit

Worldwide Consumer

MT

McCarthy Tétrault LLP

Federal Court Denies Class Action Certification In Generic Drug Price Fixing Case

Canada Healthcare

SB

Smart & Biggar

La Cour fédérale rejette une requête en autorisation de recours collectif relative à la fixation des prix de médicaments génériques

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen

Canada Healthcare

SB

Smart & Biggar

Proposed Regulatory Framework Aims To Better Support Innovative Clinical Trials In Canada

Canada Healthcare

TL

Torys LLP

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

Canada Healthcare

SB

Smart & Biggar

Canadian Product Stewardship And EPR: A Review Of 2025 And Beyond

Canada Environment

GW

Gowling WLG

L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen

Le 29 janvier 2026, l'Agence des médicaments du Canada (l'« AMC ») a publié des Améliorations au processus d'examen en vue du remboursement d'un médicament...

Canada Healthcare

SB

Smart & Biggar

Proposed Regulatory Framework Aims To Better Support Innovative Clinical Trials In Canada

In December 2025, Health Canada released proposed Clinical Trials Regulations (the proposed regulations), which would establish a new regulatory framework for clinical trials involving drugs for human use.

Canada Healthcare

TL

Torys LLP

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.

Canada Healthcare

SB

Smart & Biggar

Canadian Product Stewardship And EPR: A Review Of 2025 And Beyond

In 2025, Canadian governments and producer‑responsibility organizations ("PROs") continued advancing innovative product stewardship and extended producer responsibility...

Canada Environment

GW

Gowling WLG

New PMPRB Chairperson And PMPRB Releases January 2026 NEWSletter

Canada Healthcare

SB

Smart & Biggar

Proposed Ministerial Reliance Order Would Allow Health Canada To Rely On Decisions Of Foreign Trusted Regulators

On December 19, 2025, the Minister of Health announced the launch of consultations on two key regulatory initiatives referenced in Health Canada's Red Tape Review report...

Canada Healthcare

SB

Smart & Biggar

Revue de l'année 2025 en droit des brevets au Canada

L'année 2025 a été marquée par des changements législatifs importants et par l'audience tant attendue concernant la brevetabilité des méthodes de traitement médical devant la Cour suprême du Canada.

SB

Smart & Biggar

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Voici les articles les plus lus de la rubrique Mise à jour en PI Rx en 2025...

Canada Healthcare

SB

Smart & Biggar

Zero-Rated Or Taxable Food & Drinks?

The supplies of food and beverages that are for human consumption are generally zero-rated for GST/HST purposes in Canada – meaning that a 0% rate of tax applies...

MK

Millar Kreklewetz

Canadian Trademark Law Year In Review 2025: Notable Decisions And Updates

C

Cassels

The Canada Mutual Recognition Agreement – A Two-Way Street To The Market

FR

Fillmore Riley

Double brevet et demandes divisionnaires au Canada : des stratégies évolutives pour les demandeurs

SB

Smart & Biggar

Service Of Process: More Than A Formality

Canada Litigation

C

Cassels

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Class Action Pursued Concerning Safety Defects With GLP-1 Drugs Mounjaro, Trulicity, & Zepbound

Canada Litigation

SL

Siskinds LLP

Federal Court Of Appeal Confirms BYOOVIZ Is Confusing With Novartis' BEOVU Trademark

SB

Smart & Biggar

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Legislative Update Report No. 2025-24 Le Bulletin D'actualités Législatives

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

See more

Latest Videos

See more

Drug Pricing And Reimbursement: The Role Of Provinces And Hospitals In Pharmaceutical Pricing (Video)

TL

Torys LLP

Nutrition Tips & Advice During COVID-19 (Video)

GW

Gowling WLG

Le Secteur De La Santé Au Canada Après La COVID-19 : Perspectives Juridiques, Médicales Et Commerciales (vidéos)

SE

Stikeman Elliott LLP

What Are The Challenges And Opportunities In Ontario's Budding Cannabis Retail Market? (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Two: Weed Growth (Video)

D

Dentons Canada LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More